Theravance Biopharma Inc (TBPH)
Deferred Revenue
$0.00
Quarterly · Period ending: · USD
TBPH Deferred Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
TBPH Quarterly Deferred Revenue ($0.00 → $0.00)
Quarterly deferred revenue
High-resolution chart · PNG
TBPH deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 24,000 | |
| 24,000 | |
| 24,000 | |
| 24,000 | |
| 24,000 | |
| 24,000 | |
| 0 | |
| 98,000 | |
| 0 | |
| 5,690,000 | |
| 0 | |
| 11,523,000 | |
| 18,204,000 | |
| 25,062,000 | |
| 23,193,000 | |
| 31,575,000 | |
| 33,751,000 | |
| 43,311,000 | |
| 42,515,000 | |
| 43,402,000 | |
| 57,239,000 | |
| 54,478,000 | |
| 50,162,000 | |
| 125,000 | |
| 134,000 | |
| 142,000 | |
| 142,000 | |
| 152,000 | |
| 218,000 | |
| 662,000 | |
| 1,120,000 | |
| 144,000 | |
| 271,000 | |
| 342,000 | |
| 310,000 | |
| 89,000 | |
| 667,000 | |
| 5,723,000 | |
| 7,732,000 | |
| 8,207,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |